- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/20 - Antivirals for DNA viruses
Patent holdings for IPC class A61P 31/20
Total number of patents in this class: 3098
10-year publication summary
|
51
|
71
|
166
|
205
|
235
|
261
|
296
|
282
|
243
|
191
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
105 |
| Hoffmann-La Roche Inc. | 3523 |
102 |
| Aligos Therapeutics, Inc. | 168 |
71 |
| Janssen Sciences Ireland Unlimited Company | 398 |
69 |
| Gilead Sciences, Inc. | 2083 |
57 |
| F. Hoffmann-La Roche AG | 7931 |
54 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 714 |
31 |
| Arbutus Biopharma Corporation | 176 |
30 |
| Sunshine Lake Pharma Co., Ltd. | 600 |
29 |
| Xiamen University | 541 |
25 |
| Assembly Biosciences, Inc. | 81 |
24 |
| Sinocelltech Ltd. | 80 |
24 |
| Intervet International B.V. | 1292 |
19 |
| VIR Biotechnology, Inc. | 148 |
19 |
| Emory University | 1652 |
18 |
| Glaxosmithkline Biologicals S.A. | 1653 |
17 |
| Enanta Pharmaceuticals, Inc. | 433 |
17 |
| Intervet Inc. | 907 |
17 |
| Boehringer Ingelheim Animal Health USA Inc. | 421 |
16 |
| Novartis AG | 10635 |
14 |
| Other owners | 2340 |